GPX1 and non-small cell lung carcinoma: In this study, we showed that downregulation of GPX1 in cisplatin resistant NSCLC cell lines A549 and H1975 significantly increased intracellular accumulation of ROS, inhibited AKT phosphorylation, and further promoted proapoptotic activity of the cells upon cisplatin treatment.